Suppr超能文献

超声支气管镜引导下经支气管针吸活检术在合并胸外恶性肿瘤的胸内淋巴结病变中的应用

Endobronchial ultrasound-guided transbronchial needle aspiration in intrathoracic lymphadenopathy with extrathoracic malignancy.

作者信息

Li Shi-Jie, Wu Qi

机构信息

Endoscopy Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

出版信息

World J Clin Cases. 2022 Dec 26;10(36):13227-13238. doi: 10.12998/wjcc.v10.i36.13227.

Abstract

BACKGROUND

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis of mediastinal and hilar lymph is poorly studied in patients with extrathoracic malignancies.

AIM

To evaluate the value of EBUS-TBNA for the diagnosis of enlarged intrathoracic lymph nodes in patients with extrathoracic malignancies.

METHODS

This was a retrospective study of patients with extrathoracic malignancies who were referred to Peking University Cancer Hospital from January 2013 to December 2018 for EBUS-TBNA due to intrathoracic lymphadenopathy. The specimens were defined as positive for malignancy, negative for non-malignancy (tuberculosis, sarcoidosis, ), and without a definitive diagnosis. Sensitivity, negative predictive value (NPV) for malignancy, and overall accuracy were calculated. Complications were recorded.

RESULTS

A total of 80 patients underwent EBUS-TBNA and had a final diagnosis, among which 50 (62.5%) were diagnosed with extrathoracic malignancy with intrathoracic lymph nodes metastasis, 14 (17.5%) were diagnosed with primary lung cancer with nodal involvement, and 16 (20.0%) exhibited benign behavior including tuberculosis, sarcoidosis and reactive lymphadenitis or who had benign follow-up. The diagnostic sensitivity, NPV, and accuracy of EBUS-TBNA for intrathoracic lymphadenopathy in patients with extrathoracic malignancy were 93.8% ( = 60/64), 80.0% ( = 16/20), and 95.0% ( = 76/80), respectively. In the multivariate analysis, longer short axis of the lymph node (OR: 1.200, 95%CI: 1.024-1.407; = 0.024) and synchronous lung lesion (OR: 19.449, 95%CI: 1.875-201.753; = 0.013) were independently associated with malignant intrathoracic lymphadenopathy. No characteristics of the lymph nodes and EBUS-TBNA were associated with the location of malignant intrathoracic lymphadenopathy, and no major complication was observed.

CONCLUSION

EBUS-TBNA is a simple and accurate procedure for the diagnosis of intrathoracic lymphadenopathy with extrathoracic malignancy.

摘要

背景

对于胸外恶性肿瘤患者,经支气管超声引导下经支气管针吸活检术(EBUS-TBNA)用于诊断纵隔和肺门淋巴结的研究较少。

目的

评估EBUS-TBNA对胸外恶性肿瘤患者胸内肿大淋巴结的诊断价值。

方法

这是一项回顾性研究,研究对象为2013年1月至2018年12月因胸内淋巴结肿大转诊至北京大学肿瘤医院接受EBUS-TBNA的胸外恶性肿瘤患者。标本被定义为恶性阳性、非恶性(结核病、结节病等)阴性且未明确诊断。计算敏感性、恶性肿瘤的阴性预测值(NPV)和总体准确率。记录并发症。

结果

共有80例患者接受了EBUS-TBNA并最终确诊,其中50例(62.5%)被诊断为胸外恶性肿瘤伴胸内淋巴结转移,14例(17.5%)被诊断为原发性肺癌伴淋巴结受累,16例(20.0%)表现为良性病变,包括结核病、结节病和反应性淋巴结炎或随访结果为良性。EBUS-TBNA对胸外恶性肿瘤患者胸内淋巴结肿大的诊断敏感性、NPV和准确率分别为93.8%(=60/64)、80.0%(=16/20)和95.0%(=76/80)。在多变量分析中,淋巴结短轴较长(OR:1.200,95%CI:1.024-1.407;=0.024)和同步肺部病变(OR:19.449,95%CI:1.875-201.753;=0.013)与胸内恶性淋巴结病独立相关。淋巴结和EBUS-TBNA的特征与胸内恶性淋巴结病的位置无关,未观察到重大并发症。

结论

EBUS-TBNA是诊断胸外恶性肿瘤伴胸内淋巴结肿大的一种简单、准确的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c6f/9851006/53a8b1d9989e/WJCC-10-13227-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验